ANDA 75889, held by Quagen. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 75889 (Fluvoxamine Maleate), held by Quagen, was first approved by FDA on Nov 29, 2000, with 15 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 29, 2000 | Original application | Approved |
| Fluvoxamine Maleate25MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate50MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate100MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Aug 18, 2023 | Supplement 31Labeling · Standard review | Approved | None posted |
| Aug 10, 2023 | Supplement 26Labeling · Standard review | Approved | None posted |
| Aug 10, 2023 | Supplement 30Labeling · Standard review | Approved | None posted |
| May 8, 2015 | Supplement 24Labeling · Standard review | Approved | None posted |
| May 4, 2009 | Supplement 21Labeling | Approved | None posted |
| Oct 16, 2007 | Supplement 17Labeling | Approved | None posted |
| Jun 29, 2007 | Supplement 14Labeling | Approved | None posted |
| Jul 24, 2006 | Supplement 12Labeling | Approved | None posted |
| Jun 9, 2005 | Supplement 9Labeling | Approved | None posted |
| Apr 14, 2005 | Supplement 8Labeling | Approved | None posted |
| Jun 18, 2004 | Supplement 6Labeling | Approved | None posted |
| May 11, 2004 | Supplement 5Labeling | Approved | None posted |
| Mar 24, 2004 | Supplement 4Labeling | Approved | None posted |
| Aug 29, 2003 | Supplement 3Labeling | Approved | None posted |
| Feb 5, 2003 | Supplement 1Labeling | Approved | None posted |
| Nov 29, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters